Purchase Order 36C26126P0342

The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 15, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetic devices to support the VA Palo Alto Health Care System. This award carries no set-aside designation and represents a restocking procurement executed under the company's existing five-year, $6.5 million indefinite delivery contract with VISN 21 for surgical implant consignment services, effective through December 31, 2030. The consignment model enables the VA facility to maintain optimized inventory levels of Edwards Lifesciences' specialized cardiac devices, which have short shelf lives and are essential for advanced cardiovascular surgical procedures serving the veteran patient population.

Edwards Lifesciences LLC, a self-certified small disadvantaged business and subsidiary of Edwards Lifesciences Corporation, serves as the primary supplier of advanced transcatheter heart valve systems and cardiovascular implants to the VA healthcare system across multiple service networks. The company's product portfolio includes SAPIEN 3 and SAPIEN 3 Ultra transcatheter valves, INSPIRIS RESILIA aortic valves, and PASCAL mitral valve repair systems. With over 200 prime federal contract awards predominantly issued by the Department of Veterans Affairs since 2025, Edwards Lifesciences has established itself as a critical partner in supporting specialized cardiac care delivery and ensuring consistent access to life-saving cardiovascular technologies for eligible veterans. The ultimate completion date for this purchase order is April 14, 2026, with performance occurring at the San Francisco, California location.